[entee]

I think you’re missing one of the key parts of the article: be careful. Mass administration of a drug is dangerous. As you mention early in your post, you know what you’re doing, I take you at your word. But a drug with known serious side effects shouldn’t be mass distributed without clear benefit. Studies so far are encouraging but tiny and noisy sample size. We’ll get better data soon.

Even then, if it proves effective in symptomatic cases, it’s unclear prophylactic use is called for. More sensible to administer to those with current symptoms. If truly effective this would lower fatalities and keep ICUs from being overwhelmed.

Finally, the most recent French study suggests a combination with azithromycin is the actual effective treatment. We just don’t know enough yet, we will soon, let’s be responsible.